Childhood Cancer Research Unit, Department of Woman and Child Health, Karolinska Institutet, Karolinska University Hospital Solna, Stockholm, Sweden.
Pediatr Blood Cancer. 2010 Apr;54(4):563-72. doi: 10.1002/pbc.22357.
Griscelli syndrome type 2 (GS2) is an autosomal-recessive immunodeficiency caused by mutations in RAB27A, clinically characterized by partial albinism and haemophagocytic lymphohistocytosis (HLH). We evaluated the frequency of RAB27A mutations in 21 unrelated patients with haemophagocytic syndromes without mutations in familial HLH (FHL) causing genes or an established diagnosis of GS2. In addition, we report three patients with known GS2. Moreover, neurological involvement and RAB27A mutations in previously published patients with genetically verified GS2 are reviewed.
Mutation analysis of RAB27A was performed by direct DNA sequencing. NK cell activity was evaluated and microscopy of the hair was performed to confirm the diagnosis.
RAB27A mutations were found in 1 of the 21 families. This Swedish family had three affected children with heterozygous compound mutations consisting of a novel splice error mutation, [c.239G>C], and a nonsense mutation, [c.550C>T], p.R184X. The three additional children all carried homozygous RAB27A mutations, one of which is a novel splice error mutation, [c.240-2A>C]. Of note, five of the six patients displayed neurological symptoms, while three out of six patients displayed NK cell activity within normal reference values, albeit low. A literature review revealed that 67% of GS2 patients have been reported with neurological manifestations.
Identification of RAB27A mutations can facilitate prompt diagnosis and treatment, and aid genetic counselling and prenatal diagnosis. Since five of six patients studied herein initially were diagnosed as having FHL, we conclude that the diagnosis of GS2 may be overlooked, particularly in fair-haired patients with haemophagocytic syndromes.
Griscelli 综合征 2 型(GS2)是一种常染色体隐性免疫缺陷病,由 RAB27A 基因突变引起,临床上表现为部分白化病和噬血细胞性淋巴组织细胞增生症(HLH)。我们评估了 21 例无家族性 HLH(FHL)致病基因突变且无明确 GS2 诊断的噬血细胞综合征患者中 RAB27A 基因突变的频率。此外,我们报告了 3 例已知的 GS2 患者。此外,还回顾了先前发表的经基因证实的 GS2 患者的神经受累和 RAB27A 突变情况。
通过直接 DNA 测序进行 RAB27A 突变分析。评估 NK 细胞活性并进行头发显微镜检查以确认诊断。
在 21 个家系中发现了 1 个 RAB27A 基因突变。这个瑞典家系有 3 个受影响的孩子,他们携带有杂合复合突变,包括一个新的剪接错误突变 [c.239G>C] 和一个无义突变 [c.550C>T],p.R184X。另外 3 个孩子均携带纯合 RAB27A 突变,其中一个是新的剪接错误突变 [c.240-2A>C]。值得注意的是,6 个患者中有 5 个表现出神经系统症状,而 6 个患者中有 3 个 NK 细胞活性在正常参考值范围内,但较低。文献回顾显示,67%的 GS2 患者有神经系统表现的报道。
鉴定 RAB27A 基因突变可有助于快速诊断和治疗,并有助于遗传咨询和产前诊断。由于本文研究的 6 例患者中有 5 例最初被诊断为 FHL,我们得出结论,GS2 的诊断可能被忽视,尤其是在患有噬血细胞综合征的浅发患者中。